Sana Biotechnology Inc (NASDAQ: SANA) is 29.90% higher on its value in year-to-date trading and has touched a low of $2.74 and a high of $12.00 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The SANA stock was last observed hovering at around $5.01 in the last trading session, with the day’s gains setting it 0.29%.
Currently trading at $5.30, the stock is 0.25% and -5.71% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.47 million and changing 5.79% at the moment leaves the stock -19.33% off its SMA200. SANA registered -4.68% loss for a year compared to 6-month loss of -33.67%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -15.74% gain in the last 1 month and extending the period to 3 months gives it a -36.14%, and is 11.58% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 4.72% over the week and 7.91% over the month.
Sana Biotechnology Inc (SANA) has around 328 employees, a market worth around $1.18B and $0.00M in sales. Distance from 52-week low is 93.08% and -55.83% from its 52-week high. The company has generated returns on investments over the last 12 months (-57.19%).
The EPS is expected to grow by 17.60% this year
214.0 institutions hold shares in Sana Biotechnology Inc (SANA), with institutional investors hold 98.93% of the company’s shares. The shares outstanding are 197.86M, and float is at 120.93M with Short Float at 24.65%. Institutions hold 90.42% of the Float.
The top institutional shareholder in the company is FLAGSHIP PIONEERING INC. with over 25.0 million shares valued at $250.02 million. The investor’s holdings represent 12.6709 of the SANA Shares outstanding. As of 2024-03-31, the second largest holder is FMR LLC with 22.04 million shares valued at $220.43 million to account for 11.1711 of the shares outstanding. The other top investors are VANGUARD GROUP INC which holds 12.16 million shares representing 6.1602 and valued at over $121.55 million, while BAILLIE GIFFORD & CO holds 5.4006 of the shares totaling 10.66 million with a market value of $106.56 million.
Sana Biotechnology Inc (SANA) Insider Activity
The most recent transaction is an insider sale by Yang Patrick Y, the company’s Director. SEC filings show that Yang Patrick Y sold 25,000 shares of the company’s common stock on Mar 08 ’24 at a price of $9.45 per share for a total of $0.24 million. Following the sale, the insider now owns 0.15 million shares.
Sana Biotechnology Inc disclosed in a document filed with the SEC on Feb 08 ’24 that NELSEN ROBERT (Director) bought a total of 1,818,181 shares of the company’s common stock. The trade occurred on Feb 08 ’24 and was made at $5.50 per share for $10.0 million. Following the transaction, the insider now directly holds 12.45 million shares of the SANA stock.
Still, SEC filings show that on Feb 08 ’24, CRANDELL KEITH (10% Owner) acquired 1,818,181 shares at an average price of $5.50 for $10.0 million. The insider now directly holds 12,446,022 shares of Sana Biotechnology Inc (SANA).
